BRIEF

on SARTORIUS AG (isin : DE0007165631)

Sartorius Releases 2024 Annual Report

Sartorius, a global leader in the life sciences sector, has published its Annual Report for 2024. The report, accessible online, provides insights into the company's performance over the past year. Sartorius, headquartered in Göttingen, Germany, operates extensively in the biopharmaceutical and life sciences research fields. The company offers innovative solutions through its Lab Products & Services Division and Bioprocess Solutions Division. In 2024, Sartorius reported sales revenue of approximately 3.4 billion euros with a workforce of around 13,500 employees worldwide. Key dates in the company's financial calendar include the Annual Shareholders’ Meeting on March 27, 2025, and quarterly results publications throughout 2025.

R. E.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all SARTORIUS AG news